Single hepatocellular carcinoma ranging from 3 to 5cm: radiofrequency ablation or resection?
- 1 December 2007
- journal article
- Published by Elsevier BV in HPB
- Vol. 9 (6), 429-434
- https://doi.org/10.1080/13651820701713758
Abstract
Background. The optimal therapy for hepatocellular carcinoma (HCC) is transplantation. For all those patients not eligible for transplantation (or on the waiting list) among the treatments of choice used more frequently in recent years are resection (RES) and radiofrequency ablation (RFA). RFA is less efficacious for HCC ranging over 3cm. The aim of this study was to compare RFA to RES in a restricted cohort of patients with a single naive HCC ranging from 3 to 5cm in size and without end-stage liver disease. Patients and methods. A total of 102 patients who had never been treated before were enrolled. Those patients whose HCC position would have required too much parenchymal loss at RES (central or close to main vascular structures) were treated with RFA (n=60), and the others underwent RES (n=42). The two groups were similar for HCC size and liver disease status. The outcome was considered in terms of overall survival (OS) and disease-free survival (DFS) calculated by the Kaplan–Meier method. Differences among groups were validated by log-rank test. Results. The RES group seemed to present a better long-term OS (91%, 57%, and 43% vs 96%, 53%, and 32% at 1, 3, and 5 years, respectively) and DFS (74%, 35%, and 14% vs 68%, 18%, and 0%, respectively) but there was no statistical significance. Age, gender, virus etiology, HCC size and α-fetoprotein levels did not correlate with survival. Patients with recurrence within the first 12 months after treatment showed a worse long-term survival (p=0.011). Patients in Child-Pugh class B had poor prognoses compared with those in class A (p=0.047). Conclusion. Even if RES seemed to promise better long-term results, in the medium term this difference had no statistical significance. Survival in this series was more closely related to the stage of the underlying liver disease than to treatment (RES/RFA).Keywords
This publication has 33 references indexed in Scilit:
- A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular CarcinomaGastroenterology, 2005
- Comparing the Outcomes of Radiofrequency Ablation and Surgery in Patients With a Single Small Hepatocellular Carcinoma and Well-Preserved Hepatic FunctionJournal of Clinical Gastroenterology, 2005
- [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].2005
- Complications After Percutaneous Saline-Enhanced Radiofrequency Ablation of Liver Tumors: 3-Year Experience with 336 Patients at a Single CenterAmerican Journal of Roentgenology, 2005
- Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cmGastroenterology, 2004
- Surgical Resection Versus Percutaneous Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma on Cirrhotic LiverAnnals of Surgery, 2004
- Small Hepatocellular Carcinoma in Cirrhosis: Randomized Comparison of Radio-frequency Thermal Ablation versus Percutaneous Ethanol InjectionRadiology, 2003
- Treatment of Focal Liver Tumors with Percutaneous Radio-frequency Ablation: Complications Encountered in a Multicenter StudyRadiology, 2003
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999
- Hepatic Resection for Hepatocellular Carcinoma An Audit of 343 PatientsAnnals of Surgery, 1995